mopping up the dribs and drabs of unmarketable parcels is one of the precursors to to's.
It reduces the registry expenses and feeds the stale shares into active hands - usually the agents of the wolves that are gathering, as they will be happy with their 30+%
@618 and @invertedva and to whoever asked the Q re t/o. Basically the answer was yes, words have been exchanged. Nothing definitive, but party or parties have spoken.
Stus defence is to keep the company moving, keep it active and materialise the price catalysts.
Catalysts in the near term:
- ED-1
- Booth-1 - three stacked targets, inc the 250BCF (gross) of gas (with some condensate) in the Kingia.
- Gas policy result (although you could argue this could well be stalled again as the wolves are not set yet)
- Walyering-7
- SE peaking gas plant FID
Only problem is that the main people with an appetite for the company are the wolves preparing to pounce. Now's the time imo for all the retail fence sitters. Load up, and hold out.
- Forums
- ASX - By Stock
- Ann: Webinar Registration for Q4 FY24 Financial Results
mopping up the dribs and drabs of unmarketable parcels is one of...
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add STX (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $673.3M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 23.0¢ | $2.088M | 8.896M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 595306 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 3222624 | 40 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 595306 | 0.235 |
15 | 1828836 | 0.230 |
9 | 802812 | 0.225 |
14 | 1592602 | 0.220 |
15 | 1871772 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 3222624 | 40 |
0.245 | 1634060 | 27 |
0.250 | 2432716 | 30 |
0.255 | 2676153 | 8 |
0.260 | 5036143 | 21 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
STX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online